ENPICOM
ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford
The IGX Platform integrates SAbPred, developed at the University of Oxford, to support high-throughput de-risking of antibody discovery.
Category: All
Empowering research teams: The path to accessible immune repertoire data
By democratizing Rep-Seq data analysis, scientists and collaborators can extract value directly from all data, avoiding bottlenecks that hinder innovation and development.
Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows
ENPICOM, an innovative bioinformatics software engineering company, announced today that Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative, research-based, commercial-stage biopharmaceutical company based in China and the U.S., has signed a subscription agreement for ENPICOM’s IGX Platform.
The impact of high-throughput immune repertoire sequencing on the analysis of antibody responses: A conversation with Prof. Gunilla Karlsson Hedestam of Karolinska Institute
NGS of BCR repertoires is crucial in antibody discovery and vaccine studies, allowing for detailed immune response analysis. Prof. Gunilla Karlsson Hedestam discussed the impact of high-throughput Rep-Seq on antibody and vaccine discovery.
Breaking the UX barrier: Towards user-focused biomedical software
Biomedical software needs good UX practices to tackle complex research questions. Discover how well-thought interface and experience can significantly improve and speed up biomedical data analysis.
ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery
ENPICOM announces a new Antibody Discovery Module, empowering scientists and service providers in the antibody discovery field to analyze Sanger and NGS data independently.
ENPICOM is now a corporate sponsor of The Antibody Society
The Antibody Society is an international non-profit association, founded in 2007, to represent individuals and organizations involved in antibody-related research and development. We are now pleased to announce an official corporate sponsorship of The Antibody Society.
Single-cell sequencing: Industry trends and developments
Single-cell sequencing technology has been applied in many biomedical fields, including immunology. In this post, we take a closer look at the market, forecasts, and highlight expert insights from the single-cell immune profiling industry.
Gaining a deeper understanding of the immune system: A conversation with Prof. Dirk Busch and Dr. Kilian Schober of the Technical University of Munich
Prof. Dirk Busch and Dr. Kilian Schober from the Technical University of Munich use T-cell receptor sequencing to study the T-cell response during CMV infection in humans and mice.
Fighting COVID-19 and transforming infectious disease research with immune repertoire sequencing
Explore how repertoire sequencing advances research in infectious diseases and the future of immunomics-driven therapy development.